Production of hTPO Transgenic Chickens using Tetracycline-Inducible Expression System

• Published in: Korean journal of poultry science Vol. 36; no. 2
• Main Authors: Kwon, M.S., Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, Koo, B.C., Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, Kim, D.H., Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, Kim, M.J., Catholic University of Daegu School of Medicine, Daegu, Republic of Korea, Kim, T., Catholic University of Daegu School of Medicine, Daegu, Republic of Korea
• Format: Journal Article
• Language: Korean
• Published: 01.06.2009
• Subjects: BIOREACTEUR; BIOREACTORS; BIORREACTORES; human thrombopoietin (hTPO); tetracycline-inducible expression system; transgenic chickens
• ISSN: 1225-6625

It is well-known that unregulated over-expression of foreign gene may have unwanted physiological or toxic effects in transgenic animals. To circumvent these problems, we constructed retrovirus vector designed to express the foreign gene under the control of the tetracycline-inducible promoter. However, gene expressions in the tetracycline-inducible expression system (Tet system) are not completely regulated but a little leaky due to the inherent defects in conventional Tet-based systems. A more tightly controllable regulatory system can be achieved when the advanced versions (rtTA2∨SM2) of rtTA and a minimal promoter in responsive components (pTRE-tight) are used in combination therein. In this study, we tried to produce human thrombopoietin (hTPO) from various target cells and transgenic chickens using the retrovirus vector combined with Tet system. hTPO is the primary regulator of platelet production and has an important role in the survival and expansion of hematopoietic stem cells. In a preliminary experiment in vitro, higher hTPO expression and tighter expression control were observed in chicken embryonic fibroblast (CEF) cells. We also measured the biological activity of the hTPO using Mo7e cells whose proliferation is dependant on hTPO. The biological activity of the recombinant hTPO from CEF was higher than both its commercial counterpart and hTPO from other target cells. The recombinant retrovirus was injected beneath the blastoderm of non-incubated chicken embryos (stage X). Out of 138 injected eggs, 15 chicks hatched after 21 days of incubation. Among them, 8 hatched chicks were hTPO positive. When the Go transgenic chicken was fed doxycycline (0.5 mg per 1 gram of feed), a tetracycline derivative, hTPO concentration of the transgenic chicken blood was 200 ng/mL. Germline transmission of the transgene was confirmed in sperm of the Go transgenic roosters. These results are informative to establish transgenic chickens as bioreactors for the mass production of commercially valuable and biological active human cytokine proteins.